Medicare said Thursday it’s considering a cut in enrollee premiums after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer’s drug projected to drive up program costs.
The agency “is looking at that, and is still going through the process,” spokeswoman Beth Lynk said of a potential reduction in premiums, as Medicare announced its final coverage decision for Aduhelm, a drug whose benefits have been widely questioned in the medical community.
Thursday’s decision illustrates the impact that a single medication can have on the budgets of individuals and taxpayers. It comes as legislation to authorize Medicare to negotiate prescription drug prices remains stuck in the Senate, part of President Joe Biden’s stalled social and climate agenda. But although the company slashed the price in half — to $28,000 a year — Aduhelm’s rollout has been disastrous.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Medicare limits payments for new Alzheimer’s drug to clinical trialsThe federal government affirmed its plan to limit coverage for a costly new medication for Alzheimer’s disease, restricting it to Medicare patients enrolled in clinical trials.
Leer más »
Alaska News Nightly: Thursday, April 7, 2022 - Alaska Public MediaTonight on Alaska News Nightly: The state House passes a budget amendment intended to cut Medicaid funding for abortions. And Juneau considers ending its relationship with a sister city in Russia. Listen here:
Leer más »
42 previously unknown genes discovered for Alzheimer's diseaseAn additional 42 genes connected to the development of Alzheimer's disease have been uncovered in the largest study of genetic risk for Alzheimer's to date.
Leer más »
42 previously unknown genes discovered for Alzheimer's disease in 'landmark study'An additional 42 genes connected to the development of Alzheimer's disease have been uncovered in the largest study of genetic risk for Alzheimer's to date.
Leer más »
42 previously unknown genes discovered for Alzheimer's disease in 'landmark study'An additional 42 genes connected to the development of Alzheimer's disease have been uncovered in the largest study of genetic risk for Alzheimer's to date.
Leer más »